Press Release Archive
Press Releases
October 2023
10.13.2023
10.13.2023
Prescription Medicines Medicines U.S. FDA Approves Pfizer’s VELSIPITY™ for Adults with Moderately to Severely Active Ulcerative Colitis (UC)
10.12.2023
Prescription Medicines Medicines U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
10.05.2023
10.04.2023
Financial Finance Pfizer Declares Fourth-Quarter 2023 Dividend
September 2023
09.22.2023
09.19.2023
09.19.2023
09.18.2023
09.12.2023
09.11.2023
09.05.2023
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.